Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 282 publications
Blinatumomab administration in the outpatient setting: Safety and health care utilization.
Journal: Cancer
Published: May 01, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity.
Journal: Science (New York, N.Y.)
Published: April 09, 2026
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results.
Journal: Leukemia
Published: March 05, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 11, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and Decitabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 22, 2025
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With Acute Lymphoblastic Leukemia.
Journal: American journal of hematology
Published: December 22, 2025
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 22, 2025
CAR T-cell Kinetics, Persistence, and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study.
Journal: Cancer research communications
Published: December 17, 2025
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years.
Journal: The Journal of allergy and clinical immunology
Published: December 16, 2025
Last Updated: 09/26/2026